RT @Abdelcards: "🎉 Thrilled to share our case-series on Cangrelor bridging in cardio-oncology patients with history of recent PCI @FrontCV…
332 followers
12,194 followers
RT @FrontCVMedicine: New Research: Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients wit…
332 followers
"🎉 Thrilled to share our case-series on Cangrelor bridging in cardio-oncology patients with history of recent PCI @FrontCVMedicine. 🩺❤️ Appreciate @cezar_ciliescu for the mentorship! 📚 Check it here: https://t.co/Dqzdn29MDF #CardioTwitter #CardioOncology
2,794 followers
New Research: Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer: Cangrelor, a potent intravenous P2Y12 platelet inhibitor, has demonstrated effectiveness in reducing ischemic… https://t.co/NTpW